J. P. Ferreira, K. Duarte, T. L. Graves, M. R. Zile, W. T. Abraham et al., Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials, J Am Coll Cardiol, vol.68, issue.24, pp.2690-2707, 2016.

J. Spertus, E. Peterson, M. W. Conard, P. A. Heidenreich, H. M. Krumholz et al., Monitoring clinical changes in patients with heart failure: a comparison of methods, Am Heart J, vol.150, issue.4, pp.707-722, 2005.

S. D. Anker, . .;-comin, J. Colet, G. Filippatos, R. Willenheimer et al., Ferric carboxymaltose in patients with heart failure and iron deficiency, N Engl J Med, vol.361, issue.25, pp.2436-2484, 2009.

E. F. Lewis, B. L. Claggett, J. J. Mcmurray, M. Packer, M. P. Lefkowitz et al., Health-Related Quality of Life Outcomes in PARADIGM-HF, Circ Heart Fail, issue.8, p.10, 2017.

J. J. Mcmurray, M. Packer, A. S. Desai, J. Gong, M. P. Lefkowitz et al., Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med, vol.371, issue.11, pp.993-1004, 2014.

J. J. Mcmurray, S. D. Solomon, S. E. Inzucchi, L. Kober, M. N. Kosiborod et al., N Engl J Med, 2019.

B. Pitt, M. A. Pfeffer, S. F. Assmann, R. Boineau, I. S. Anand et al., Spironolactone for heart failure with preserved ejection fraction, N Engl J Med, vol.370, issue.15, pp.1383-92, 2014.

M. A. Pfeffer, B. Claggett, S. F. Assmann, R. Boineau, I. S. Anand et al., Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial, Circulation, vol.131, issue.1, pp.34-42, 2015.

S. D. Solomon, J. J. Mcmurray, I. S. Anand, J. Ge, C. S. Lam et al., Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction, N Engl J Med, 2019.

N. Luo, C. M. O'connor, L. B. Cooper, J. L. Sun, A. Coles et al., Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION, Eur J Heart Fail, vol.21, issue.1, pp.63-70, 2019.

Y. N. Reddy, A. Rikhi, M. Obokata, S. J. Shah, G. D. Lewis et al., Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity, Eur J Heart Fail, 2020.

J. P. Ferreira, The use of the win ratio in cardiovascular trials, 2020.